Ganaxolone May Help Reduce Seizures in Epilepsy Patients
Researchers conducted a systematic review to evaluate the effectiveness of a new medication called ganaxolone for treating seizures in people with epilepsy.
This hub covers epilepsy genetics: how gene changes can contribute to seizures (often in children). We translate studies on testing, results like VUS, and what findings may change for care.
No. It’s common in pediatrics, but adults can benefit from genetic testing, too, especially with unclear diagnosis or family history.
Sometimes. For certain conditions, results can guide medication choice, diet therapies, or referral decisions.
It usually means “not enough evidence yet.” It shouldn’t be treated as a definite cause, but it can be reclassified over time.
Not necessarily. Testing can miss some variants, and new gene links are still being discovered.
Researchers conducted a systematic review to evaluate the effectiveness of a new medication called ganaxolone for treating seizures in people with epilepsy.
Researchers studied two sisters who showed signs of growth issues and various physical and neurological features.
Researchers studied the roles of two types of brain cells, called parvalbumin (PV) and somatostatin (SOM) interneurons, in controlling brain activity patterns known as oscillations.
Researchers studied the effects of three types of carbapenem antibioticsβimipenem, meropenem, and ertapenemβon mice to understand their potential to cause seizures.
Researchers conducted a study to explore the connection between cognitive dysfunction and serum neuron-specific enolase (NSE) levels in patients with systemic lupus erythematosus (SLE).
Researchers examined the role of the hippocampus, a key part of the brain involved in memory and emotion, in the development of epilepsy.
Researchers investigated a new treatment approach for epilepsy that combines two natural compounds, fisetin and carveol, using specially designed lipid nanocapsules to help deliver the medication directly to the brain.
Researchers studied two specific genetic variants in the KCNMA1 gene, which are linked to neurological disorders, including epilepsy.
Researchers studied the role of the PHF21A gene in brain development and epilepsy.